Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.25 | 5.36480686695 | 4.66 | 5.16 | 4.05 | 236486 | 4.85573191 | CS |
| 4 | 0.81 | 19.756097561 | 4.1 | 5.5 | 3.8113 | 223979 | 4.65200203 | CS |
| 12 | -0.03 | -0.607287449393 | 4.94 | 7.2 | 2.92 | 345050 | 5.15449191 | CS |
| 26 | -1.64 | -25.0381679389 | 6.55 | 7.93 | 2.92 | 296544 | 5.17110626 | CS |
| 52 | -1.64 | -25.0381679389 | 6.55 | 7.93 | 2.92 | 296544 | 5.17110626 | CS |
| 156 | -1.64 | -25.0381679389 | 6.55 | 7.93 | 2.92 | 296544 | 5.17110626 | CS |
| 260 | -1.64 | -25.0381679389 | 6.55 | 7.93 | 2.92 | 296544 | 5.17110626 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
